CT urography: definition, indications and techniques. A guideline for clinical practice.

Department of Radiology C-2S, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
European Radiology (Impact Factor: 4.34). 02/2008; 18(1):4-17. DOI: 10.1007/s00330-007-0792-x
Source: PubMed

ABSTRACT The aim was to develop clinical guidelines for multidetector computed tomography urography (CTU) by a group of experts from the European Society of Urogenital Radiology (ESUR). Peer-reviewed papers and reviews were systematically scrutinized. A summary document was produced and discussed at the ESUR 2006 and ECR 2007 meetings with the goal to reach consensus. True evidence-based guidelines could not be formulated, but expert guidelines on indications and CTU examination technique were produced. CTU is justified as a first-line test for patients with macroscopic haematuria, at high-risk for urothelial cancer. Otherwise, CTU may be used as a problem-solving examination. A differential approach using a one-, two- or three-phase protocol is proposed, whereby the clinical indication and the patient population will determine which CTU protocol is employed. Either a combined nephrographic-excretory phase following a split-bolus intravenous injection of contrast medium, or separate nephrographic and excretory phases following a single-bolus injection can be used. Lower dose (CTDIvol 5-6 mGy) is used for benign conditions and normal dose (CTDIvol 9-12 mGy) for potential malignant disease. A low-dose (CTDIvol 2-3 mGy) unenhanced series can be added on indication. The expert-based CTU guidelines provide recommendations to optimize techniques and to unify the radiologist's approach to CTU.

  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE. The purpose of this study was to evaluate the diagnostic performance of a dedicated dual-source dual-energy MDCT (DECT) protocol for the detection of urothelial tumors. MATERIALS AND METHODS. A DECT protocol including furosemide and split-bolus contrast injection was used in 69 consecutive patients with suspected abnormalities of the urinary system. Thirteen patients were excluded because there was no follow-up available. In 56 patients, the final diagnosis was proven with endoscopy, biopsy, or follow-up and included urothelial tumors (n = 37) in 16 patients, other urinary tract pathologies (n = 9) in eight patients, and absence of lesions of the collecting system in 32 patients. The image series consisted of a dual-energy true unenhanced series, 35-second arterial phase, and 8-minute nephrographic-excretory phase and were analyzed retrospectively. True enhancement of all detected lesions was measured. On the basis of the DECT data of the contrast-enhanced images, virtual unenhanced series were created and iodine concentration was calculated using commercially available software. The attenuation difference between virtual unenhanced and contrast-enhanced images (virtual enhancement) was measured. CT findings were compared with the final diagnosis. RESULTS. Urothelial tumors were identified on 35-second series, 8-minute series, and both series combined, with sensitivity of 91.9% (95% CI, 78.1-98.2%), 83.4% (68.0-93.8%), and 97.3% (85.8-100%), respectively. Urothelial tumors showed stronger virtual enhancement (p = 0.02) and higher iodine concentration (p = 0.03) than lesions of other origin. Distinction between urothelial tumors and nontumoral lesions was possible with sensitivity of 91.9% (78.1-98.2%) when using a threshold concentration of at least 1.0 mg I/mL. CONCLUSION. Dual phase DECT with virtual unenhanced imaging and iodine concentration measurement appears to be a useful diagnostic test for urothelial tumors.
    American Journal of Roentgenology 04/2014; 202(4):W357-64. · 2.90 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: With growing ketamine abuse, ketamine-induced uropathy (KIU) has become more prevalent in recent years. This research evaluates the presence, distribution and extent of KIU in the upper and lower urinary tracts by retrospectively reviewing CT urography (CTU) images. Patients diagnosed with KIU who underwent CT scanning from 1 January 2006 to 31 December 2011 were recruited. The CT protocols included three-phase CTU in six patients, split-bolus CTU in 17, two-phase CT in one and unenhanced CT in three. The CT images were retrospectively reviewed by two radiologists. A total of 27 patients participated in this study. The common CT findings included diffuse bladder wall thickening (88.9%), small bladder volume (66.7%) and perivesical inflammation (44.4%). Twelve patients (44.4%) were diagnosed with hydronephrosis, including three patients with unilateral hydronephrosis and nine with bilateral hydronephrosis. Of these patients, nine had ureteral wall thickening (33.3%) and two (7.4%) had ureterovesical junction involvement (ie, they had hydronephrosis but no ureteral wall thickening). One patient had a ureteral obstruction because of a ureter stone. The correlation between upper urinary tract involvement and grading of the interstitial cystitis was statistically non-significant (p=0.33). Four patients (14.8%) had a vesicovaginal fistula which could be detected in the excretory phase only. Upper urinary tract involvement is common in patients with KIU. CTU might aid evaluation of the extent of KIU and prompt adequate management.
    Postgraduate medical journal 01/2014; · 1.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE. The purpose of this article is to describe the current consensus guidelines for nonimaging triage and ultimate preferred imaging approach for the patient with unexplained hematuria. CONCLUSION. Numerous consensus guidelines from varying societies have outlined preferred imaging pathways for the patient with unexplained urologic causes of hematuria. Future guidelines will need to take into account disease prevalence, radiation considerations, and cost.
    AJR. American journal of roentgenology. 06/2014; 202(6):1179-86.

Full-text (3 Sources)

Available from
May 15, 2014